Vardenafil Hydrochloride Tablet, Film Coated
Product Images NDC 62332-238

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 62332-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil 10 mg

The label for Vardenafil Hydrochloride Tablets 10 mg, film-coated tablets for oral use, contains 30 tablets per package. It includes the NDC 62332-238-30, manufacturer Alembic Pharmaceuticals Inc., and dosage instructions to take one tablet as needed. The label features storage recommendations and notes the product is Rx only.*

FDA Label Image

Vardenafil 20 mg

Vardenafil Hydrochloride Tablets 20 mg film-coated tablets package label. The label includes the NDC number 62332-239-30, indicates a quantity of 30 tablets, and states the labeler as Alembic Pharmaceuticals Inc. The label shows drug description, usual dosage, recommended storage, and a barcode. Markings include 'Rx only' and a note that the packaging is child-resistant.*

FDA Label Image

Figure 1 (Vardenafil Figure1)

A set of three line graphs depicting mean maximal changes in systolic blood pressure, diastolic blood pressure, and heart rate over time relative to vardenafil treatment timing before NTG (nitroglycerin). The x-axis shows timing intervals (24h, 8h, 4h, 1h), and the y-axis measures the magnitude of change for each parameter (mmHg for BP, bpm for heart rate) with error bars indicating variability.*

FDA Label Image

Figure 2 (Vardenafil Figure2)

Line graph showing mean change in mmHg over time in hours (0 to 6) for placebo and Vardenafil 5 mg tablets under simultaneous and 6-hour separation conditions. The graph illustrates variations in blood pressure measurements with different treatment timing.*

FDA Label Image

Figure 3 (Vardenafil Figure3)

A line graph depicting mean change in mmHg on the y-axis against time in hours on the x-axis, comparing the effects of placebo and 5 mg vardenafil given simultaneously and with a 6-hour separation. The graph displays four curves representing these groups over a 6-hour period.*

FDA Label Image

Figure 4 (Vardenafil Figure4)

A line graph showing mean change in mmHg over time (hours) comparing Vardenafil 10 mg, Vardenafil 20 mg, and placebo (Stages 1 and 2). The y-axis represents mean change in mmHg, while the x-axis represents time in hours up to 6 hours. Data points for each treatment group are connected with distinct markers illustrating blood pressure changes over time.*

FDA Label Image

Figure 5 (Vardenafil Figure5)

A line graph showing mean change in mmHg on the y-axis over time in hours on the x-axis. It compares placebo and vardenafil at 5 mg and 10 mg dosages during two different stages, illustrating trends in blood pressure changes over a 6-hour period.*

FDA Label Image

Figure 6 (Vardenafil Figure6)

A line graph depicting mean change in mmHg over time (hours) comparing placebo and varying doses of Vardenafil (10 mg and 20 mg) with Terazosin. The graph includes separate lines for 6-hour separation and simultaneous administration of the drugs, showing blood pressure changes measured up to 6 hours.*

FDA Label Image

Figure 7 (Vardenafil Figure7)

A line graph depicting mean change in mmHg over time (hours) related to Tamsulosin. It compares placebo with 10 mg and 20 mg doses of Vardenafil under conditions of 6-hour separation and simultaneous administration, showing trends of blood pressure changes across a 6-hour period.*

FDA Label Image

Figure 8 (Vardenafil Figure8)

Pharmacokinetic graph illustrating plasma concentration of Vardenafil Hydrochloride (µg/L) over time (hours). The curve shows peak concentration shortly after administration, followed by a gradual decline extending to 24 hours, with error bars indicating variability at each time point.*

FDA Label Image

Vardenafil mg 25

The packaging label for Vardenafil Hydrochloride Tablets from Alembic Pharmaceuticals Inc. displays the 2.5 mg strength of film-coated tablets. The label includes NDC 62332-236-30, a 30-tablet package count, and indicates prescription use only. The label also features a barcode and storage instructions.*

FDA Label Image

Vardenafil mg 5

Vardenafil Hydrochloride Tablets 5 mg film-coated oral tablets carton label by Alembic Pharmaceuticals Inc. The label features dosage strength (5 mg) in a yellow box, NDC 62332-237-30, and a 30-tablet count. Storage instructions and dosage recommendations are partially visible. Includes manufacturer and barcode information.*

FDA Label Image

Structure (Vardenafil Str)

Chemical structure diagram of Vardenafil Hydrochloride, showing its molecular configuration including the heterocyclic rings, ethyl and piperazine groups, sulfonyl linkage, and hydration with hydrochloride and three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.